Company patents
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. demonstrates a strong, albeit shifting, focus within pharmaceutical innovation, with Heterocyclic Compounds representing a dominant 82.5% of its portfolio, despite a -36.4% decline in patent filings so far in 2026. While Therapeutic Activity also shows a significant presence at 61.9% of the portfolio, the company has surprisingly shown an emerging focus on Pharmaceutical Preparations, which experienced a 100.0% year-over-year growth in 2024 and a 25.0% growth in 2025, indicating a strategic pivot towards drug formulation and delivery.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
63 US filings (since 2023) · 4 categories · 8 themes
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.
Therapeutic strategies employing nucleic acids (DNA, RNA, oligonucleotides) to modulate gene expression, deliver genetic material, or interfere with disease-causing pathways. Includes gene therapy using viral vectors.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Techniques for preparing and characterizing specific solid forms, such as crystal forms, salts, co-crystals, or amorphous forms, of active pharmaceutical ingredients to optimize properties like stability, solubility, and bioavailability.
Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.
Therapeutic interventions that target immune checkpoint pathways to either enhance or suppress immune responses, often used in cancer immunotherapy or autoimmune diseases.
Patents
Showing 1-2 of 2
API Solid Form Engineering